Academic, Collaborations, Competitor News, Data Partnership, International, Japan

Japan’s Omi Medical Center, Seikoukai, Becomes the First Healthcare Organization in Western Japan to Sign a Partnership Agreement with TriNetX to Increase Participation in Multi-National Clinical Trials

CAMBRIDGE, Mass., Feb. 27, 2023 /PRNewswire/ — Omi Medical Center, part of the Seikoukai Social Medical Corporation and one of Japan’s leading institutions in the use of advanced medical technologies, announced it is partnering with TriNetX to increase its exposure and participation in multi-national industry-sponsored clinical trials. “The use of Japanese pharmaceuticals has dropped from 20%…

Collaborations, Competitor News, Europe, International

ConcertAI’s TeraRecon Inks Distribution Deals with Seven AI Developers Alongside EU Launch of Eureka Clinical AI Platform at #ECR23

The leading open Clinical AI platform allows users to develop and deploy their own AI algorithms and leverage third-party AI algorithms within existing clinical workflows. CAMBRIDGE, Mass., Feb. 27, 2023 /PRNewswire/ — ConcertAI’s TeraRecon, advanced visualization and AI Clinical SaaS category leader, has announced its Eureka Clinical AI platform is now available to European healthcare…

Collaborations, Competitor News

PULSEPOINT LAUNCHES ALL-CHANNEL MEASUREMENT FOR INSIGHT-DRIVEN CONSUMER ACTIVATION IN PARTNERSHIP WITH KOMODO HEALTH

Integrated Measurement Delivers Actionable, Privacy-Safe Patient Insights for Real-Time Planning, Activation, and Optimization NEW YORK, Feb. 27, 2023 /PRNewswire/ — PulsePoint, a technology company revolutionizing health decision-making in real time, today announced the launch of integrated direct-to-consumer (DTC) measurement solutions in partnership with Komodo Health, a leading healthcare technology company that has…

AI, Collaborations, Competitor News

ConcertAI’s TeraRecon Inks Distribution Deals with Seven AI Developers Alongside EU Launch of Eureka Clinical AI Platform at #ECR23

The leading open Clinical AI platform allows users to develop and deploy their own AI algorithms and leverage third-party AI algorithms within existing clinical workflows. CAMBRIDGE, Mass., Feb. 27, 2023 /PRNewswire/ — ConcertAI’s TeraRecon, advanced visualization and AI Clinical SaaS category leader, has announced its Eureka Clinical AI platform is now available to European healthcare…

AI, Collaborations, Competitor News

ConcertAI’s TeraRecon, in Us2.AI Partnership, Integrates AI-Enabled Echocardiography Decision Support into Eureka Clinical AI Platform

The Industry’s leading AI SaaS solution for Acute Cardiac Care bringing critical patient insights to patients’ care teams faster. CAMBRIDGE, Mass., Feb. 24, 2023 /PRNewswire/ — ConcertAI’s TeraRecon Eureka Clinical AI SaaS platform brings artificial intelligence (AI) and Deep Learning technologies to fully automate a complete echocardiography or heart ultrasound report.  Us2.ai’s FDA-cleared and CE Marked echocardiogram…

AI, Competitor News, Product Updates

ConcertAI’s TeraRecon Integrates AI-based Chest Solutions into Eureka Clinical AI Platform through Riverain Technologies Partnership

Breadth and Depth of Integrations Across Lung Imaging Acquisition, Reading and Reporting, and Care Coordination Enhance Customer Workflow and Access CAMBRIDGE, Mass., Feb. 23, 2023 /PRNewswire/ — ConcertAI’s TeraRecon Eureka Clinical AI SaaS platform brings artificial intelligence (AI) and Deep Learning technologies to automate thoracic image interpretation for improved accuracy and accelerated interpretation.  This provides a comprehensive AI solution for multi-specialty care teams that improves patient care….

Blogs/Publications, Competitor News, Marketing

Truveta’s COVID-19 breakthrough infections research published in Vaccine

In a study of more than 1.2 million patients, new research shows the interaction effects of multiple comorbidities on the increased risk of COVID-19 breakthrough infections and hospitalizations. February 23, 2023 09:00 ET | Source: Truveta BELLEVUE, Wash., Feb. 23, 2023 (GLOBE NEWSWIRE) — Today Truveta announced new COVID-19 research published in Vaccine using…

Academic, Competitor News, Interviews, Marketing, Synthetic Data

How synthetic data can boost efficiency for clinical researchers and IT leaders

Washington University and Ottawa Hospital used synthetic data to review a sepsis prediction model used in both institutions over the course of two phone calls – and avoided months of conventional research arrangements. By Bill Siwicki February 23, 2023 10:49 AM Josh Rubel, chief commercial officer of MDClone Photo: Josh Rubel Hospitals…

Collaborations, Competitor News

Xspray Pharma Partners with EVERSANA® for the U.S. Launch and Commercialization of its Lead Product, Dasynoc (XS004) for the Treatment of Chronic Myeloid Leukemia (CML) and Acute Lymphatic Leukemia (ALL)

STOCKHOLM, Feb. 23, 2023 /PRNewswire/ — Xspray Pharma AB, (NASDAQ Stockholm: XSPRAY) has signed an agreement with EVERSANA® to support the U.S. launch and commercialization of the company’s first innovative cancer therapy Dasynoc for the treatment of chronic myeloid leukemia (CML) and acute lymphatic leukemia (ALL). While maintaining financial and strategic control, Xspray Pharma will grant…